Literature DB >> 21880726

Interaction of nectin-like molecule 2 with integrin alpha6beta4 and inhibition of disassembly of integrin alpha6beta4 from hemidesmosomes.

Kiyohito Mizutani1, Satoshi Kawano, Akihiro Minami, Masazumi Waseda, Wataru Ikeda, Yoshimi Takai.   

Abstract

In normal epithelial cells, integrin α(6)β(4) is abundantly expressed and forms hemidesmosomes, which is a cellular structure that mediates cell-extracellular matrix binding. In many types of cancer cells, integrin α(6)β(4) is up-regulated, laminin is cleaved, and hemidesmosomes are disrupted, eventually causing an enhancement of cancer cell movement and facilitation of their invasion. We previously showed that the immunoglobulin-like cell adhesion molecule Necl-2 (Nectin-like molecule 2), known as a tumor suppressor, inhibits cancer cell movement by suppressing the ErbB3/ErbB2 signaling. We show here that Necl-2 interacts in cis with integrin α(6)β(4). The binding of Necl-2 with integrin β(4) was mediated by its extracellular region. In human colorectal adenocarcinoma Caco-2 cells, integrin α(6)β(4) was localized at hemidesmosomes. Small interfering RNA-mediated suppression of Necl-2 expression enhanced the phorbol ester-induced disruption of the integrin α(6)β(4) complex at hemidesmosomes, whereas expression of Necl-2 suppressed the disruption of this structure. These results indicate that tumor-suppressive functions of Necl-2 are mediated by the stabilization of the hemidesmosome structure in addition to the inhibition of the ErbB3/ErbB2 signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880726      PMCID: PMC3196104          DOI: 10.1074/jbc.M110.200535

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

Review 1.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

2.  The tumor suppressor protein TSLC1 is involved in cell-cell adhesion.

Authors:  Mari Masuda; Mika Yageta; Hiroshi Fukuhara; Masami Kuramochi; Tomoko Maruyama; Akio Nomoto; Yoshinori Murakami
Journal:  J Biol Chem       Date:  2002-06-05       Impact factor: 5.157

3.  Nectin-1alpha, an immunoglobulin-like receptor involved in the formation of synapses, is a substrate for presenilin/gamma-secretase-like cleavage.

Authors:  Doo Yeon Kim; Laura A MacKenzie Ingano; Dora M Kovacs
Journal:  J Biol Chem       Date:  2002-10-09       Impact factor: 5.157

4.  Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer.

Authors:  Mika Yageta; Masami Kuramochi; Mari Masuda; Takeshi Fukami; Hiroshi Fukuhara; Tomoko Maruyama; Masabumi Shibuya; Yoshinori Murakami
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

5.  Identification of the Tslc1 gene, a mouse orthologue of the human tumor suppressor TSLC1 gene.

Authors:  Takeshi Fukami; Hitoshi Satoh; Eriko Fujita; Tomoko Maruyama; Hiroshi Fukuhara; Masami Kuramochi; Shinichi Takamoto; Takashi Momoi; Yoshinori Murakami
Journal:  Gene       Date:  2002-07-24       Impact factor: 3.688

6.  Ectodomain shedding of nectin-1alpha by SF/HGF and TPA in MDCK cells.

Authors:  Yoshinari Tanaka; Kenji Irie; Takeshi Hirota; Toshiaki Sakisaka; Hiroyuki Nakanishi; Yoshimi Takai
Journal:  Biochem Biophys Res Commun       Date:  2002-12-06       Impact factor: 3.575

7.  Tage4/Nectin-like molecule-5 heterophilically trans-interacts with cell adhesion molecule Nectin-3 and enhances cell migration.

Authors:  Wataru Ikeda; Shigeki Kakunaga; Shinsuke Itoh; Tatsushi Shingai; Kyoji Takekuni; Keiko Satoh; Yoko Inoue; Akiko Hamaguchi; Koji Morimoto; Masakazu Takeuchi; Toshio Imai; Yoshimi Takai
Journal:  J Biol Chem       Date:  2003-05-11       Impact factor: 5.157

8.  Association of a lung tumor suppressor TSLC1 with MPP3, a human homologue of Drosophila tumor suppressor Dlg.

Authors:  Hiroshi Fukuhara; Mari Masuda; Mika Yageta; Takeshi Fukami; Masami Kuramochi; Tomoko Maruyama; Tadaichi Kitamura; Yoshinori Murakami; Mari Masvuda
Journal:  Oncogene       Date:  2003-09-18       Impact factor: 9.867

9.  Implications of nectin-like molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in cell-cell adhesion and transmembrane protein localization in epithelial cells.

Authors:  Tatsushi Shingai; Wataru Ikeda; Shigeki Kakunaga; Koji Morimoto; Kyoji Takekuni; Shinsuke Itoh; Keiko Satoh; Masakazu Takeuchi; Toshio Imai; Morito Monden; Yoshimi Takai
Journal:  J Biol Chem       Date:  2003-06-25       Impact factor: 5.157

10.  Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma.

Authors:  H K Kleinman; M L McGarvey; L A Liotta; P G Robey; K Tryggvason; G R Martin
Journal:  Biochemistry       Date:  1982-11-23       Impact factor: 3.162

View more
  12 in total

1.  Genetic deletion of Cadm4 results in myelin abnormalities resembling Charcot-Marie-Tooth neuropathy.

Authors:  Neev Golan; Elena Kartvelishvily; Ivo Spiegel; Daniela Salomon; Helena Sabanay; Katya Rechav; Anya Vainshtein; Shahar Frechter; Galia Maik-Rachline; Yael Eshed-Eisenbach; Takashi Momoi; Elior Peles
Journal:  J Neurosci       Date:  2013-07-03       Impact factor: 6.167

2.  Nectin-4 co-stimulates the prolactin receptor by interacting with SOCS1 and inhibiting its activity on the JAK2-STAT5a signaling pathway.

Authors:  Masahiro Maruoka; Shin Kedashiro; Yuki Ueda; Kiyohito Mizutani; Yoshimi Takai
Journal:  J Biol Chem       Date:  2017-03-03       Impact factor: 5.157

Review 3.  Natural history of hepatic metastases from colorectal cancer--pathobiological pathways with clinical significance.

Authors:  Konstantinos A Paschos; Ali W Majeed; Nigel C Bird
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

4.  Human T-cell leukemia virus type 1 (HTLV-1) tax requires CADM1/TSLC1 for inactivation of the NF-κB inhibitor A20 and constitutive NF-κB signaling.

Authors:  Rajeshree Pujari; Richard Hunte; Remy Thomas; Louise van der Weyden; Dan Rauch; Lee Ratner; Jennifer K Nyborg; Juan Carlos Ramos; Yoshimi Takai; Noula Shembade
Journal:  PLoS Pathog       Date:  2015-03-16       Impact factor: 6.823

5.  CRTAM controls residency of gut CD4+CD8+ T cells in the steady state and maintenance of gut CD4+ Th17 during parasitic infection.

Authors:  Victor S Cortez; Luisa Cervantes-Barragan; Christina Song; Susan Gilfillan; Keely G McDonald; Roxane Tussiwand; Brian T Edelson; Yoshinori Murakami; Kenneth M Murphy; Rodney D Newberry; L David Sibley; Marco Colonna
Journal:  J Exp Med       Date:  2014-03-31       Impact factor: 14.307

6.  Redundant Postsynaptic Functions of SynCAMs 1-3 during Synapse Formation.

Authors:  Daniel K Fowler; James H Peters; Carly Williams; Philip Washbourne
Journal:  Front Mol Neurosci       Date:  2017-01-31       Impact factor: 5.639

7.  CADM1 controls actin cytoskeleton assembly and regulates extracellular matrix adhesion in human mast cells.

Authors:  Elena P Moiseeva; Kees R Straatman; Mark L Leyland; Peter Bradding
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

8.  CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity.

Authors:  Sabari Vallath; Elizabeth K Sage; Krishna K Kolluri; Sofia N Lourenco; Vitor S Teixeira; Suneeta Chimalapati; P Jeremy George; Sam M Janes; Adam Giangreco
Journal:  Sci Rep       Date:  2016-04-01       Impact factor: 4.379

9.  Nectin-like molecule-4/cell adhesion molecule 4 inhibits the ligand-induced dimerization of ErbB3 with ErbB2.

Authors:  Kiyohito Mizutani; Shin Kedashiro; Masahiro Maruoka; Yuki Ueda; Yoshimi Takai
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

10.  CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation.

Authors:  Richard Hunte; Patricia Alonso; Remy Thomas; Cassandra Alexandria Bazile; Juan Carlos Ramos; Louise van der Weyden; Juan Dominguez-Bendala; Wasif Noor Khan; Noula Shembade
Journal:  PLoS Pathog       Date:  2018-04-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.